论文部分内容阅读
目的 :观察支气管动脉灌注化疗治疗原发性肺癌近期疗效 ,并配合参麦注射液免疫治疗对肺癌患者生存质量的影响。方法 :5 0 0 m A X线机 ,选用美国 Cook公司生产的动脉导管 ,采用 Seldinger法经股动脉穿刺插管至支气管动脉 ,配合参麦注射液免疫治疗。结果 :3次化疗后临床症状基本消失率 (93% ) ,骨髓抑制发生率为零 ,胃肠道反应发生较低 ,提高了生存质量。结论 :动脉导管灌注化疗配合参麦注射免疫治疗肺癌近期疗效肯定 ,也是术前化疗安全有效的方法
Objective: To observe the short-term curative effect of bronchial artery infusion chemotherapy for primary lung cancer and to observe the effect of Shenmai injection immunotherapy on the quality of life of lung cancer patients. Methods: A 500 m A X-ray machine was used. The catheter was produced by Cook Company in the United States. Seldinger method was used to intubate the bronchial artery through the femoral artery puncture and receive the immunotherapy with Shenmai injection. Results: After three times of chemotherapy, the clinical symptoms disappeared (93%), the incidence of myelosuppression was zero, the gastrointestinal reaction was lower, and the quality of life was improved. Conclusion: Ductal catheterization of chemotherapy with shenmai injection of lung cancer in the near future treatment of positive effect, but also preoperative chemotherapy is safe and effective method